Rosemary Tannock, PhD
The Hospital for Sick Children
Senior Scientist, Psychiatry Research
Neurosciences & Mental Health
University of Toronto
- Attention Deficit Hyperactivity Disorder
- Neurodevelopmental Disorders (Reading Disorder, Specific Language Impairments, Selective Mutism)
- Cognitive function (inhibition, working memory, language)
- Clinical trials (psychotropic medication, academic intervention)
- Developmental neuropsychology
Future Research Interests
Current research in my lab is focusing on working memory, inhibition, and comprehension of spoken and written language. We are interested in the normal development of these critical aspects of cognitive function, their efficiency in various neurodevelopmental disorders (ADHD, reading disorder, specific language impairments), and their sensitivity to specific treatment modalities (pharmacological,cognitive-behavioural).
In my clinical research program, we investigate the cognitive mechanisms and treatment of attention-deficit hyperactivity disorder (ADHD) and co-occurring disorders. Our methods allow us to determine the independence of the cognitive processes, the specificity of their association with each disorder, and the effects of stimulant medication. Our collaborative initiative with the Toronto District Board of Education investigates the most effective treatment for a difficult-to-treat group of children with combined ADHD and reading disorder.
These two disorders are important, not only because of their prevalence and long-term negative outcome, but also because they pose critical questions for child development - the relations among genetic, biological, and environmental factors.
A detailed list of Dr. Tannock's publications is available at Pub Med.
Search Dr. Tannock's publications >>